Stay updated on LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial
Sign up to get notified when there's something new on the LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial page.

Latest updates to the LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check44 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check51 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check65 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check72 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check101 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial page.